AMR & Infectious Diseases Q4 2023 | A promotional supplement distributed on behalf of Mediaplanet, which takes sole responsibility for its content
www.globalcause.co.uk
“We must increase our use of diagnostic tools to ensure valuable new antibiotics remain effective for many years.”
“We no longer have time to stall because pathogens don’t.”
James Anderson, Chair, AMR Industry Alliance
Remko van Leeuwen, Vice President, BEAM Alliance
Page 06
Page 08